Abstract
Purpose
Cardiopulmonary bypass induces an ischaemia–reperfusion injury and systemic inflammatory response, which contributes to low cardiac output syndrome following cardiac surgery. Exogenous nitric oxide during cardiopulmonary bypass has shown potential to ameliorate such injury. We undertook a large randomised controlled trial to investigate the clinical effects of administering nitric oxide to the cardiopulmonary bypass circuit in children.
Methods
After written informed consent, children were randomised to receive 20 ppm nitric oxide to the gas inflow of the cardiopulmonary bypass oxygenator, or standard conduct of bypass.
Results
101 children received nitric oxide and developed low cardiac output syndrome less frequently (15 vs. 31 %, p = 0.007) than the 97 children who did not receive nitric oxide. This effect was most marked in children aged less than 6 weeks of age (20 vs. 52 %, p = 0.012) and in those aged 6 weeks to 2 years (6 vs. 24 %, p = 0.026), who also had significantly reduced ICU length of stay (43 vs. 84 h, p = 0.031). Low cardiac output syndrome was less frequent following more complex surgeries if nitric oxide was administered (17 vs. 48 %, p = 0.018). ECMO was used less often in the nitric oxide group (1 vs. 8 %, p = 0.014).
Conclusions
Delivery of nitric oxide to the oxygenator gas flow during paediatric cardiopulmonary bypass reduced the incidence of low cardiac output syndrome by varying degrees, according to age group and surgery complexity.
Clinical Trial Registration: ACTRN12615001376538.
Similar content being viewed by others
References
Wernovsky G, Wypij D, Jonas RA, Mayer JE, Hanley FL, Hickey PR, Walsh AZ, Chang AC, Castaneda AR, Newburger JW, Wesser DL (1995) Postoperative course and haemodynamic profile after the arterial switch operation in neonates and infants: a comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation 92:2226–2235
Hoffman TM, Wernovsky G, Atz AM, Kulik TJ, Nelson DP, Chang AC, Bailey JM, Akbary A, Kocsis JF, Kaczmarek R, Spray TL, Wessel DL (2003) Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 107:996–1002
Ma M, Guavreau K, Allan CK, Mayer JE, Jenkins JK (2007) Causes of death after congenital heart surgery. Ann Thorac Surg 83(4):1438–1445
Paparella D, Yau TM, Young E (2002) Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg 21:232–244
Guzik TJ, Korbut R, Adamek-Guzik T (2003) Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol 54(4):469–487
Rossaint R, Lewandowski K, Zapol WM (2014) Our paper 20 years later: inhaled nitric oxide for the acute respiratory distress syndrome—discovery, current understanding, and focussed targets of future applications. Intensive Care Med 40(11):1649–1658
Uchiyama T, Otani H, Okada T, Ninomiya H, Kido M, Imamura H (2002) Nitric oxide induces caspase-dependent apoptosis and necrosis in neonatal rat cardiomyocytes. J Mol Cell Cadiol 34:1049–1061
Sawicki G, Salas E, Murat J, Miszta-Lane H, Radomski MW (1997) Release of gelatinase A during platelet activation mediates aggregation. Nature 386:616–619
Comini L, Bachetti T, Agnoletti L, Gaia G, Curello S, Milanesi B (1999) Induction of functional inducible nitric oxide synthetase in monocytes of patients with congestive heart failure: link with tumour necrosis factor-alpha. Eur Heart J 20:1503–1513
Van Dervort AL, Yan L, Madara PJ, Cobb JP, Wesley RA, Corriveau CC (1994) Nitric oxide regulates endotoxin-induced TNF-alpha production by human neutrophils. J Immunol 152:4102–4109
Zakkar M, Guida G, Suleiman MS, Angelini GD (2015) Cardiopulmonary bypass and oxidative stress. Oxid Med Cell Longev 2015:189863
Phillips L, Toledo AH, Lopez-Neblina F, Anaya-Prado R, Toledo-Pereyra LH (2009) Nitric oxide mechanism of protection in ischaemia and reperfusion injury. J Invest Surg 22(1):46–55
Godiez-Rubi M, Rojas-Mayorquin AE, Ortuno-Satiaguin D (2013) Nitric oxide donors as neuroprotective agents after ischaemic stroke related inflammatory reaction. Oxid Med Cell Longev 2013:297357. doi:10.1155/2013/297357
Jones SP, Bolli R (2006) The ubiquitous role of nitric oxide in cardioprotection. J Mol Cell Cardiol 40(1):16–23
Lin X, Huang Y, Pokreisz P, Vermeersch P, Marsboom G, Swinnen M, Verbeken E, Santos J, Pelles M, Gillijns H, Van de Wert F, Bloch K, Janssens S (2007) Nitric oxide inhalation improves microvascular flow and decreases infarction size after myocardial ischaemia and reperfusion. J Am Coll Cardiol 50(8):808–817
Nagasaka Y, Fernandez BO, Garcia-Saura MF, Petersen B, Ichinose F, Bloch KD, Feelisch M, Zapol WM (2008) Brief periods of nitric oxide inhalation protect against myocardial ischaemia-reperfusion injury. Anesthesiology 109(4):675–682
Gianetti J, Del Sarto P, Bevilacqua S, Vassalle C, De Filippis R, Kacila M, Farreti PA, Clerico A, Glauber M, Biagini A (2004) Supplemental nitric oxide and its effect on myocardial injury and function in patients undergoing cardiac surgery with extracorporeal circulation. J Thorac Cardiovasc Surg 127(1):44–50
Checchia P, Bronicki R, Muenzer J, Dixon D, Raithel S, Gandhi S, Huddleston C (2013) Nitric oxide delivery during cardiopulmonary bypass reduces postoperative morbidity in children—a randomised controlled trial. J Thorac Cardiovasc Surg 146(3):530–536
James C, Horton S, Brizard C, Molesworth C, Millar J, Butt W (2015) Nitric oxide during cardiopulmonary bypass improves clinical outcome: a blinded, randomized controlled trial. Circulation 132:A14827
Gaies M, Gurney J, Yen A, Napoli M, Gajarski R, Ohye R, Charpie J, Hirsch J (2010) Vasoactive-inotrope score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass. Pediatr Crit Care Med 11:234–238
Duke T, Stocker C, Butt W (2004) Monitoring children after cardiac surgery: a minimalist approach might be maximally effective. Crit Care Res 6:306–310
Robert S, Borasino S, Dabal R, Cleveland D, Hock K, Alten J (2015) Postoperative hydrocortisone infusion reduces the prevalence of low cardiac output syndrome after neonatal cardiopulmonary bypass. Pediatr Crit Care Med 16(7):629–636
Oualha M, Urien S, Spreux-Varoquaux O, Bordessoule A, D’Agostino I, Pouard P, Treluyer JM (2014) Pharmacokinetics, haemodynamic and metabolic effects of epinephrine to prevent post-operative low cardiac output syndrome in children. Crit Care 18(1):R23
Kleiber N, de Wildt S, Cortina G, Clifford M, van Rosmalen J, van Dijk M, Tibboel D, Millar J (2016) A comparative analysis of pre-emptive versus targeted sedation on cardiovascular stability after high-risk cardiac surgery in infants. Pediatr Crit Care Med 17(4):321–331
Kozik DJ, Tweddell JS (2006) Characterizing the inflammatory response to cardiopulmonary bypass in children. Ann Thorac Surg 81(6):S2347–S2354
Bronicki RA, Chang AC (2011) Management of the postoperative pediatric cardiac surgical patient. Crit Care Med 39(8):1974–1984
Mascio CE, Austin EH, Jacobs JP, Jacobs ML, Wallace AS, He X, Pasquali SK (2014) Perioperative mechanical circulatory support in children: an analysis of the Society of Thoracic Surgeons Congenital Heart Surgery Database. J Thorac Cardiovasc Surg 147(2):658–665
Lei C, Berra L, Rezoagali E, Yu B, Strelow S, Nordio F, Bonventre J, Xiong L, Zapol W (2015) Prevention of acute kidney injury by nitric oxide during and after prolonged cardiopulmonary bypass. A double blind randomized controlled trial. Abstract presentation, American Heart Association Scientific Sessions, Orlando, Florida, Nov 2015
Rassaf T, Kleinbongard P, Kelm M (2005) Circulating NO pool in humans. Kidney Blood Press Res 28:341–348
Bhatraju P, Crawford J, Hall M, Lang JD (2015) Inhaled nitric oxide: current clinical concepts. Nitric Oxide 31(50):114–128
Liu C, Liu X, Janes J, Stapley R, Patel RP, Gladwin MT, Kim-Shapiro DB (2014) Mechanism of faster NO scavenging by older stored red blood cells. Redox Biol 10(2):211–219
Zimring JC (2015) Established and theoretical factors to consider in assessing the red cell storage lesion. Blood 125(14):2185–2190
Fischer UM, Schindler R, Brixius K, Mehlhorn U, Bloch W (2007) Extracorporeal circulation activates endothelial nitric oxide synthase in erythrocytes. Ann Thorac Surg 84(6):2000–2003
Bolli R (2001) Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischaemia and preconditioning: an overview of a decade of research. J Mol Cell Cardiol 33(11):1897–1918
Lang JD, Smith AB, Brandon A, Bradley KM, Liu Y, Li W, Crowe DR, Jhala NC, Cross RC, Frennette L, Martay K, Vater YL, Vitin AA, Dembo GA, DuBay DA, Bynon JS, Szychowski JM, Reyes JD, Halldorson JB, Rayhill SC, Dick AA, Bakthavatsalam R, Brandenberger J, Broeckel-Elrod JA, Sissons-Ross L, Jordan T, Chen LY, Siriussawakul A, Eckhoff DE, Patel RP (2014) A randomized clinical trial testing the anti-inflammatory effects of preemptive inhaled nitric oxide in human liver transplantation. PLoS One 9(2):e86053
Mathru M, Huda R, Solanki DR, Hays S, Lang JD (2007) Inhaled nitric oxide attenuates reperfusion inflammatory responses in humans. Anesthesiology 106(2):275–282
Keh D, Gerlach M, Kurer KJ, Gerlach H (1996) Reduction of platelet trapping in membrane oxygenators by transmembraneous application of gaseous nitric oxide. Int J Artif Organs 19(5):291–293
Mellgren K, Friberg LG, Mellgren G, Hedner T, Wennmalm A, Wadenvik H (1996) Nitric oxide in the oxygenator sweep gas reduces platelet activation during experimental perfusion. Ann Thorac Surg 61(4):1194–1198
Chello M, Mastroroberto P, Marchese AR, Maltese G, Santangelo E, Amantea B (1998) Nitric oxide inhibits neutrophil adhesion during experimental extracorporeal circulation. Anesthesiology 89(2):443–448
Harvey MJ, Gaies MG, Prosser LA (2015) US and international in-hospital costs of extracorporeal membrane oxygenation: a systematic review. Appl Health Econ Health Policy 13(4):341–357
Maitre B, Djibre M, Katsahian S, Habibi A, Stankovic Stojanovic K, Khellaf M, Bourgeon I, Lionnet F, Charles-Nelson A, Brochard L, Lemaire F, Galacteros F, Brun-Buisson C, Fartoukh M, Mekontso Dessap A (2015) Inhaled nitric oxide for acute chest syndrome in adult sickle cell patients: a randomized controlled study. Intensive Care Med 41(12):2121–2129
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding sources
None.
Conflicts of interest
WB has received payment for educational activities by Ikaria Australia.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
James, C., Millar, J., Horton, S. et al. Nitric oxide administration during paediatric cardiopulmonary bypass: a randomised controlled trial. Intensive Care Med 42, 1744–1752 (2016). https://doi.org/10.1007/s00134-016-4420-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-016-4420-6